Home Cart 0 Sign in  
X

[ CAS No. 10602-03-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 10602-03-6
Chemical Structure| 10602-03-6
Chemical Structure| 10602-03-6
Structure of 10602-03-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10602-03-6 ]

Related Doc. of [ 10602-03-6 ]

Alternatived Products of [ 10602-03-6 ]

Product Details of [ 10602-03-6 ]

CAS No. :10602-03-6 MDL No. :MFCD00168821
Formula : C11H10O2 Boiling Point : -
Linear Structure Formula :- InChI Key :CKAGLAFXBLZHAS-UHFFFAOYSA-N
M.W : 174.20 Pubchem ID :15540683
Synonyms :

Calculated chemistry of [ 10602-03-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.18
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.46
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.31 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.66
Log Po/w (XLOGP3) : 2.89
Log Po/w (WLOGP) : 1.92
Log Po/w (MLOGP) : 2.76
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.88
Solubility : 0.227 mg/ml ; 0.00131 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.138 mg/ml ; 0.00079 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.96
Solubility : 0.192 mg/ml ; 0.0011 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.86

Safety of [ 10602-03-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10602-03-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10602-03-6 ]
  • Downstream synthetic route of [ 10602-03-6 ]

[ 10602-03-6 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 10602-03-6 ]
  • [ 7153-22-2 ]
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 18, p. 3056 - 3059
  • 2
  • [ 10602-03-6 ]
  • [ 10602-00-3 ]
Reference: [1] Dalton Transactions, 2009, # 44, p. 9794 - 9799
[2] Journal of Organic Chemistry, 1966, vol. 31, p. 2585 - 2593
  • 3
  • [ 10602-03-6 ]
  • [ 10602-04-7 ]
Reference: [1] Journal of Organic Chemistry, 1966, vol. 31, p. 2585 - 2593
  • 4
  • [ 150969-54-3 ]
  • [ 10602-03-6 ]
YieldReaction ConditionsOperation in experiment
95% With potassium carbonate In methanol at 20℃; for 2 h; Inert atmosphere General procedure: Some of the requisite aryl substituted terminal acetylenes (5) used as substrate in the preparation of the 1,2,3-triazole library of betulinic acid were prepared employing “Sonogashira reaction”[1] followed by base induced desilylation (Scheme 1), while rest of the acetylenes (5a, 5b, 5c and 5g) were purchased from commercial sources. Thus, iodide 6 (500 mg) was allowed to react with trimethyl silyl acetylene (1.5 eqv.) at room temperature in the presence of Pd(PPh3)2Cl2 (2 molpercent ), CuI (4 molpercent) and triethylamine (0.5 mL) in dry DMF under argon atmosphere to yield the intermediate product 7, which was desilylated by treating with a solution of K2CO3 (1 eqv.) dissolved in dry methanol (4.0 mL) to yield the terminal acetylene 5.
94% at 20℃; for 2 h; S3: K2CO3 (0.426 g, 3.044 mmol) was added to a solution of S2 (0.250 g, 1.01 mmol) in MeOH (10 mL) and stirred at room temperature for 2 h. The solid material was isolated by filtration and the solvent was removed in vacuo. The residue was then dissolved in CH2Cl2 (5 mL) before being washed with H2O (3 mL x 2) and brine (3 mL). The organic phase was then dried (Na2SO4). The solvent was removed in vacuo. Column chromatography (SiO2: Hexanes / CH2Cl2 = 3: 1) afforded the product S3 as a white solid (0.180 g, 94percent). IH NMR (500 MHz, CDC13): δ = 7.97 (d, 2H, Ar-Ha, 3J = 8.7 Hz), 7.54 (d, 2H, Ar-Hb, 3J = 8.7 Hz), 3.92 (s, 3H, OCH3), 3.23 (s, I H, CDCH). 13C NMR (CDCl3, 125 MHz): δ = 166.3, 131.9, 130.0, 129.3, 126.6, 82.7, 79.9, 52.1. HiRes MS (ESI-TOF): Calcd. for [M + H]+ C10H9O2+ = 161.0597; found m/z = 161.0590. (see, e.g., Fig. 8).
90% at 20℃; for 4 h; Synthesis of compound 15 is as follows: A mixture of compound 14 (3.7 g, 15 mmol) and K2CO3 (4.14 g, 30 mmol) in ethanol (500 mL) was degassed with nitrogen for 30 min. The mixture solution was stirred at room temperature for 4 h. After removing the solvent, the residue was treated with water and CH2Cl2. The aqueous phase was extracted with CH2Cl2 twice. The combined organic layer was dried over anhydrous MgSO4. The solvents were removed under reduced pressure to obtain compound 14 as red-yellow oil (2.35 g, 90percent). No further purification was necessary. 1H NMR (500 MHz, CDCl3): ? = 8.00 (d, J =8.5 Hz, 2H), 7.55 (d, J =8.5 Hz, 2H), 4.38 (m, 2H), 3.22 (s, IH), 1.39 (t, J =8.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) ? 166.3, 132.5 131.0, 130.0, 127.1, 83.3, 80.6, 61.6, 14.8.
66% With methanol; tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 6 h; Inert atmosphere 1.33 g (14 mmol) of trimethylsilylacetylene was added to a deoxygenated solution of 2.56 g (9.1 mmol) of compound 7, 102 mg (0.15 mmol) of Pd(PPh3)2C12, and 42 mg (0.22 mmol) of Cul in 30 mL of Et3N. The reaction solution was stirred at room temperature under argon overnight. The solvent was removed, and the solid was purified by flash chromatography on silica gel with hexane to yield a compound 8 (1.81 g, 81 ). A solution of 0.81 g (3.29 mmol) of compound 8 in 20 mL of methanol was deoxygenated for 30 min and 1.0 M tetrabutylammonium fluoride solution in THF (9.95 mmol) was added to the flask under argon and the mixture was stirred at room temperature for 6h. The solvent was removed and re-dissolved in methylene chloride and extracted with water twice. The combined organic solution was dried over MgS04 and the solvent was removed at reduced pressure to yield a compound 9 (0.38g, 66 ).
66% With tetrabutyl ammonium fluoride In tetrahydrofuran; methanol at 20℃; for 6 h; Inert atmosphere 1.33 g (14 rnmol) of trimethyJsiiylacetylene was added to a deoxygenated solution of 2.56 g (9.1 mmol) of compound 7, 102 mg (0.15 mmol) of Pd(PPh3)2Cl2, and 42 mg (0.22 mmol) of Cul in 30 mL of Et3N. The reaction soluiion was stirred at room temperature under argon overnight. The solvent was removed, and the solid was purified by flash chromatography on silica gel with hexane to yield a compound 8 (1.81 g, 81 percent). A solution of 0.81 g (3.29 mmol) of compound 8 in 20 mL of methanol was deoxygenated for 30 min and 1.0 M tetrabutylammonium fluoride solution in THF (9.95 mmol) was added to the flask under argon and the mixture was stirred at room temperature for 6h. The solvent was removed and re-dissolved in methylene chloride and extracted with water twice. The combined organic solution was dried over MgS04 and the solvent was removed at reduced pressure to yield a compound 9 (0.38g, 66 percent). Ή NMR (500 MHz, CfX 'l . s δ 7.80 (d, 2H), 7.54 (d, 2H), 4.38 (m, 2H), 3.24 (s, M l ). 1.39 (t, 3H).
0.87 g With potassium hydroxide In tetrahydrofuran; methanol; water at 20℃; Inert atmosphere General procedure: In a glovebox were combined aryl bromide, Pd(PPh3)2Cl2 (5 molpercent), triphenylphosphine (10 molpercent), THF (50 mL), and triethylamine (10 mL). After stirring 3 min, CuI (5 molpercent) was added and the solution was stirred another 1 min. TMS-acetylene (1.5 eq.) was then added and the reaction vessel was sealed and heated to 60 °C for 18 h. The reaction mixture was cooled, concentrated, and the residue was purified by silica gel chromatography. The obtained intermediate was then dissolved in THF (50 mL), methanol (25 mL), and a 20 percent KOH solution (aq, 15 mL) in 250 mL round bottom flask and stirred overnight at room temperature. The solution was diluted with ethyl ether (150 mL) and extracted twice with brine (50 mL). The organic layer was collected and concentrated to give a residue that was purified by silica gel chromatography.

Reference: [1] Chemistry - A European Journal, 2011, vol. 17, # 34, p. 9320 - 9325
[2] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 93 - 105
[3] Patent: WO2009/149381, 2009, A2, . Location in patent: Page/Page column 32
[4] Journal of Polymer Science, Part A: Polymer Chemistry, 2011, vol. 49, # 1, p. 211 - 224
[5] Journal of the American Chemical Society, 2015, vol. 137, # 1, p. 413 - 419
[6] Journal of Medicinal Chemistry, 2000, vol. 43, # 20, p. 3736 - 3745
[7] Organic and Biomolecular Chemistry, 2015, vol. 13, # 33, p. 8886 - 8892
[8] Patent: WO2009/158606, 2009, A2, . Location in patent: Page/Page column 5
[9] Patent: WO2012/9472, 2012, A2, . Location in patent: Page/Page column 3; 7
[10] Patent: WO2013/20096, 2013, A2, . Location in patent: Page/Page column 47-48
[11] Journal of the American Chemical Society, 1997, vol. 119, # 27, p. 6345 - 6359
[12] Chemical and Pharmaceutical Bulletin, 1999, vol. 47, # 3, p. 398 - 404
[13] Tetrahedron Letters, 2004, vol. 45, # 8, p. 1693 - 1697
[14] Tetrahedron Letters, 2015, vol. 56, # 51, p. 7105 - 7107
[15] Advanced Synthesis and Catalysis, 2016, vol. 358, # 15, p. 2436 - 2442
[16] European Journal of Organic Chemistry, 2016, vol. 2016, # 18, p. 3056 - 3059
  • 5
  • [ 51934-41-9 ]
  • [ 1066-54-2 ]
  • [ 10602-03-6 ]
Reference: [1] Chemistry Letters, 2013, vol. 42, # 10, p. 1308 - 1310
[2] Patent: CN104151174, 2016, B, . Location in patent: Paragraph 0011; 0020; 0021
  • 6
  • [ 51934-41-9 ]
  • [ 10602-03-6 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 8, p. 1693 - 1697
[2] Journal of Medicinal Chemistry, 2000, vol. 43, # 20, p. 3736 - 3745
[3] Journal of the American Chemical Society, 1997, vol. 119, # 27, p. 6345 - 6359
[4] Chemistry - A European Journal, 2011, vol. 17, # 34, p. 9320 - 9325
[5] Patent: WO2012/9472, 2012, A2,
[6] Patent: WO2013/20096, 2013, A2,
[7] Journal of the American Chemical Society, 2015, vol. 137, # 1, p. 413 - 419
[8] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 93 - 105
[9] Organic and Biomolecular Chemistry, 2015, vol. 13, # 33, p. 8886 - 8892
  • 7
  • [ 51934-41-9 ]
  • [ 7681-65-4 ]
  • [ 1066-54-2 ]
  • [ 10602-03-6 ]
Reference: [1] Patent: US2002/120006, 2002, A1,
[2] Patent: US6624154, 2003, B1,
  • 8
  • [ 64-17-5 ]
  • [ 62480-31-3 ]
  • [ 10602-03-6 ]
Reference: [1] Molecular Crystals and Liquid Crystals, 2017, vol. 647, # 1, p. 395 - 404
  • 9
  • [ 994-89-8 ]
  • [ 348-06-1 ]
  • [ 10602-03-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 16, p. 2865 - 2869
  • 10
  • [ 5798-75-4 ]
  • [ 10602-03-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1999, vol. 47, # 3, p. 398 - 404
[2] Journal of Polymer Science, Part A: Polymer Chemistry, 2011, vol. 49, # 1, p. 211 - 224
[3] Tetrahedron Letters, 2015, vol. 56, # 51, p. 7105 - 7107
[4] European Journal of Organic Chemistry, 2016, vol. 2016, # 18, p. 3056 - 3059
[5] Journal of the Brazilian Chemical Society, 2018, vol. 29, # 1, p. 109 - 124
[6] Molecular Crystals and Liquid Crystals, 2017, vol. 647, # 1, p. 395 - 404
  • 11
  • [ 51934-41-9 ]
  • [ 10602-03-6 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 15, p. 4601 - 4605
  • 12
  • [ 94-09-7 ]
  • [ 10602-03-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 16, p. 2865 - 2869
  • 13
  • [ 586-76-5 ]
  • [ 10602-03-6 ]
Reference: [1] Journal of Polymer Science, Part A: Polymer Chemistry, 2011, vol. 49, # 1, p. 211 - 224
[2] Molecular Crystals and Liquid Crystals, 2017, vol. 647, # 1, p. 395 - 404
  • 14
  • [ 144693-66-3 ]
  • [ 10602-03-6 ]
Reference: [1] Molecular Crystals and Liquid Crystals, 2017, vol. 647, # 1, p. 395 - 404
  • 15
  • [ 6929-96-0 ]
  • [ 623-47-2 ]
  • [ 10602-03-6 ]
  • [ 178742-95-5 ]
Reference: [1] Liebigs Annales, 1996, # 5, p. 815 - 824
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 10602-03-6 ]

Aryls

Chemical Structure| 10602-06-9

[ 10602-06-9 ]

Methyl 3-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 3034-86-4

[ 3034-86-4 ]

Methyl 4-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 914943-91-2

[ 914943-91-2 ]

tert-Butyl 3-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 111291-97-5

[ 111291-97-5 ]

tert-Butyl 4-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 18699-48-4

[ 18699-48-4 ]

Diisobutyl terephthalate

Similarity: 0.89

Alkynes

Chemical Structure| 10602-06-9

[ 10602-06-9 ]

Methyl 3-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 3034-86-4

[ 3034-86-4 ]

Methyl 4-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 914943-91-2

[ 914943-91-2 ]

tert-Butyl 3-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 111291-97-5

[ 111291-97-5 ]

tert-Butyl 4-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 33577-99-0

[ 33577-99-0 ]

Methyl 2-ethynylbenzoate

Similarity: 0.88

Esters

Chemical Structure| 10602-06-9

[ 10602-06-9 ]

Methyl 3-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 3034-86-4

[ 3034-86-4 ]

Methyl 4-ethynylbenzoate

Similarity: 0.96

Chemical Structure| 914943-91-2

[ 914943-91-2 ]

tert-Butyl 3-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 111291-97-5

[ 111291-97-5 ]

tert-Butyl 4-ethynylbenzoate

Similarity: 0.94

Chemical Structure| 18699-48-4

[ 18699-48-4 ]

Diisobutyl terephthalate

Similarity: 0.89